News
Abzena appoints Anu Bansal Ph.D. as Senior Director of Manufacturing at Bristol, Pennsylvania facility
Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Anu Bansal as Senior Director of Manufacturing at its facility in Bristol, Pennsylvania.
With more than...
News
Lee Pharma to launch favipiravir under brand name Faravir
Lee Pharma has received DCGI’s approval for manufacturing and marketing of active pharmaceutical ingredients (API) for favipiravir in India.
The company also plans to manufacture and market favipiravir medicine, for COVID-19 treatment. Raghu Mitra Alla, Director, Lee Pharma informed that...
Clinical Trials
Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced the beginning of a Phase 2b clinical trial in South Africa to evaluate the efficacy of NVX-CoV2373, Novavax’ COVID-19 vaccine candidate. Dr. Shabir Madhi, Professor...
News
Sanofi to acquire Principia Biopharma
Sanofi and Principia Biopharma Inc., a late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases, entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Principia for $100 per share in cash,...
News
Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Hengrui Therapeutics, Inc.
Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Hengrui Therapeutics, Inc. (HTI), a U.S. subsidiary of Chinese pharmaceutical company Jiangsu Hengrui Medicine Co., Ltd. (JHM), to develop a CDx that will leverage the Oncomine Precision Assay,...
News
COVID-19: Potential Vaccines and Logistics
While pharmaceuticals contribute to approximately 2% of annual air cargo volume, the industry transports over one trillion dollars’ worth of cargo every year (IATA). Pharmaceutical shipments have an overwhelmingly large impact on the global response to infectious diseases and...
News
China grants country’s first Covid-19 vaccine patent to CanSino
China's vaccine maker CanSino Biologics Inc has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, People's Daily reported, citing documents from the country's intellectual property regulator. The patent was submitted for application on March 18,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.